Peer-reviewedCC BY 4.0Frontiers in Psychiatry
Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report
- 1National University Health System (Singapore)
- 2Ministry of Health Holdings Pte Ltd
Abstract
Clozapine has been consistently found to be superior to other antipsychotic medications for the treatment of treatment-resistant schizophrenia, specifically in improving persistent psychotic symptoms. It is also associated with an improved quality of life as well as lower hospitalization rates, reduced suicidality, and premature mortality. Despite its lower risk of extrapyramidal side effects (EPS), clozapine is not considered first-line treatment for schizophrenia due to its array of adverse reactions. Rarely, clozapine may cause eosinophilia. We present a case of a 24-year-old Asian patient with treatment-resistant schizophrenia who developed eosinophilic cryptitis and crypt abscess after initiation of clozapine.
Related
- Bacteroides fragilis Abscess Associated With Fat Necrosis Following Breast Augmentation With Autologous Fat Grafting: A Case Report With Review of the Literature.
- Staphylococcus epidermidis-associated brain abscess following endovascular treatment of a ruptured intracranial aneurysm: potential immune-inflammatory mechanisms—a case report and literature review
- Cariprazine Augmentation and Sustained Remission of Physical Aggression in Clozapine-Treated Treatment-Resistant Schizophrenia: A Case Report.
- Achieving clinical and histologic remission with tezepelumab in an adolescent with refractory eosinophilic gastrointestinal disease: A case report
- An elusive diagnosis: pericardial effusion and hypereosinophilia revealing seronegative eosinophilic granulomatosis with polyangitis: a case report
BibTeX
@article{chong2026eosinophilic,
title = {{Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report}},
author = {Edmund Xiu Ming Chong and Nicholas Jeyanesan Abraham and Sue Ying Teoh},
journal = {Frontiers in Psychiatry},
year = {2026},
month = nov,
doi = {10.3389/fpsyt.2026.1997733},
url = {https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1997733/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report
AU - Edmund Xiu Ming Chong
AU - Nicholas Jeyanesan Abraham
AU - Sue Ying Teoh
PY - 2026
DA - 2026/11/16
JO - Frontiers in Psychiatry
DO - 10.3389/fpsyt.2026.1997733
UR - https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1997733/full
AB - Clozapine has been consistently found to be superior to other antipsychotic medications for the treatment of treatment-resistant schizophrenia, specifically in improving persistent psychotic symptoms. It is also associated with an improved quality of life as well as lower hospitalization rates, reduced suicidality, and premature mortality. Despite its lower risk of extrapyramidal side effects (EPS), clozapine is not considered first-line treatment for schizophrenia due to its array of adverse reactions. Rarely, clozapine may cause eosinophilia. We present a case of a 24-year-old Asian patient with treatment-resistant schizophrenia who developed eosinophilic cryptitis and crypt abscess after initiation of clozapine.
SN - 1664-0640
ER -